IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 8.75
-1.50 (-14.63%)
At close: Feb 12, 2026
IXICO Market Cap
IXICO has a market cap or net worth of 8.11 million as of February 12, 2026. Its market cap has decreased by -27.08% in one year.
Market Cap
8.11M
Enterprise Value
4.75M
Revenue
6.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.75
Market Cap Chart
Since October 15, 2013, IXICO's market cap has decreased from 8.82M to 8.11M, a decrease of -8.09%. That is a compound annual growth rate of -0.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 9.50M | -12.77% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 25.62M |
| Sareum Holdings | 23.47M |
| Fusion Antibodies | 19.07M |
| Oxford BioDynamics | 12.23M |
| Genflow Biosciences | 10.36M |
| Futura Medical | 8.14M |
| OptiBiotix Health | 7.90M |
| CRISM Therapeutics | 7.24M |